Contribution of inflammasome complex in inflammatory-related eye disorders and its implications for anti-inflammasome therapy

References

• Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39(6):1003–1018.
   PubMed Web of Science ®Google Scholar
• Wooff Y, Man SM, Aggio-Bruce R, et al. IL-1 family members mediate cell death, inflammation and angiogenesis in retinal degenerative diseases. Front Immunol. 2019;10:1618–1618.
   PubMed Web of Science ®Google Scholar
• Planck SR, Woods A, Clowers JS, et al. Impact of IL-1 signalling on experimental uveitis and arthritis. Ann Rheum Dis. 2012;71(5):753–760.
   PubMed Web of Science ®Google Scholar
• Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Visual Sci. 2001;42(10):2283–2292.
   PubMed Web of Science ®Google Scholar
• Sutterwala FS, Ogura Y, Flavell RA. The inflammasome in pathogen recognition and inflammation. J Leukoc Biol. 2007;82(2):259–264.
   PubMed Web of Science ®Google Scholar
• Weber A, Wasiliew P, Kracht M. Interleukin-1beta (IL-1beta) processing pathway. Sci Signal. 2010;3(105):cm2.
   PubMed Web of Science ®Google Scholar
• Blumberg D, Skaat A, Liebmann JM. Emerging risk factors for glaucoma onset and progression. Prog Brain Res. 2015;221:81–101.
   PubMed Web of Science ®Google Scholar
• Kordes M, Matuschewski K, Hafalla JC. Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria. Infect Immun. 2011;79(9):3633–3641.
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Núñez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci. 2016;41(12):1012–1021.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281(1):8–27.
   PubMed Web of Science ®Google Scholar
• Chaurasia SS, Lim RR, Parikh BH, et al. The NLRP3 inflammasome may contribute to pathologic neovascularization in the advanced stages of diabetic retinopathy. Sci Rep. 2018;8(1):2847.
   PubMedGoogle Scholar
• Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012;28:137–161.
   PubMed Web of Science ®Google Scholar
• Loukovaara S, Piippo N, Kinnunen K, et al. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy. Acta Ophthalmol. 2017;95(8):803–808.
   PubMed Web of Science ®Google Scholar
• Pronin A, Pham D, An W, et al. Inflammasome Activation Induces Pyroptosis in the Retina Exposed to Ocular Hypertension Injury. Front Mol Neurosci. 2019;12:36–36.
   PubMed Web of Science ®Google Scholar
• Szabo G, Csak T. Inflammasome in liver diseases. J hepatol. 2012;57:642–54.
   PubMed Web of Science ®Google Scholar
• Leemans JC, Cassel SL, Sutterwala FS. Sensing damage by the NLRP3 inflammasome. Immunol Rev. 2011;43(1):152–162.
   Google Scholar
• Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407–420.
   PubMed Web of Science ®Google Scholar
• Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677–687.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157(5):1013–22.
   PubMed Web of Science ®Google Scholar
• Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol. 2012;13(4):333–342.
   PubMed Web of Science ®Google Scholar
• Van Opdenbosch N, Lamkanfi M. Caspases in Cell Death, Inflammation, and Disease. Immunity. 2019;50(6):1352–1364.
   PubMed Web of Science ®Google Scholar
• Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol. 2010;10(2):89–102.
   PubMed Web of Science ®Google Scholar
• Voronov E, Carmi Y, Apte RN. The role IL-1 in tumor-mediated angiogenesis. Front Physiol. 2014;5:114.
   PubMed Web of Science ®Google Scholar
• Barclay W, Shinohara ML. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Brain Pathol. 2017;27(2):213–219.
   PubMed Web of Science ®Google Scholar
• Deuteraiou K, Kitas G, Garyfallos A, et al. Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases. Rheumatol Int. 2018;38(8):1345–1354.
   PubMed Web of Science ®Google Scholar
• Nouri HR, Karkhah A, Mohammadzadeh I, et al. Elevated caspase1 activity and IL1beta expression are associated with the IPAF inflammasome in an experimental model of allergy. Molecular Medicine Reports. 2016;13(4):3356–3362.
   PubMed Web of Science ®Google Scholar
• Saadi M, Karkhah A, Pourabdolhossein F, et al. Involveme1 nt of NLRC4 inflammasome through caspase-1 and IL-1β augments neuroinflammation and contributes to memory impairment in an experimental model of Alzheimer's like disease. Brain Res Bull. 2020;154:81–90.
   PubMed Web of Science ®Google Scholar
• Rostamtabar M, Esmaeilzadeh S, Karkhah A, et al. Elevated expression of IL-18 but not IL-1beta gene is associated with NALP3 and AIM2 inflammasome in Polycystic Ovary Syndrome. Gene. 2020; 731:144352.
   PubMed Web of Science ®Google Scholar
• Strowig T, Henao-Mejia J, Elinav E, et al. Inflammasomes in health and disease. Nature. 2012;481(7381):278–286.
   PubMed Web of Science ®Google Scholar
• Rasoulinejad SA, Kasiri A, Montazeri M, et al. The association between primary open angle glaucoma and clustered components of metabolic syndrome. Open Ophthalmol J. 2015;9:149–155.
   PubMed Web of Science ®Google Scholar
• Rasoulinejad SA, Mikanikey E, Hosseini SR, et al. The study of the frequency of hypertensive retinopathy in the elderly at Amirkola Town during 2011-2012. Babol-Jbums. 2015;17(9):24–28.
   Google Scholar
• Russo R, Varano GP, Adornetto A, et al. Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation. Eur J Pharmacol. 2016;787:134–142.
   PubMed Web of Science ®Google Scholar
• Soto I, Howell GR. The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med. 2014;4(8):a017269.
   PubMed Web of Science ®Google Scholar
• Chi W, Li F, Chen H, et al. Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma. Proc Natl Acad Sci USA. 2014;111(30):11181–11186.
   PubMed Web of Science ®Google Scholar
• Chavarria-Smith J, Vance RE. The NLRP1 inflammasomes. Immunol Rev. 2015;265(1):22–34.
   PubMed Web of Science ®Google Scholar
• Yang X, Luo C, Cai J, et al. Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina. Invest Ophthalmol Vis Sci. 2011;52(11):8442–8454.
   PubMed Web of Science ®Google Scholar
• Yang H, Antoine DJ, Andersson U, et al. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol. 2013;93(6):865–873.
   PubMed Web of Science ®Google Scholar
• Schallenberg M, Prokosch V, Thanos S. Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat model. PloS One. 2012;7(7):e33593.
   PubMed Web of Science ®Google Scholar
• Harris HE, Andersson U, Pisetsky DS. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol. 2012;8(4):195–202.
   PubMed Web of Science ®Google Scholar
• Chi W, Chen H, Li F, et al. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma . J Neuroinflammation. 2015;12:137.
   PubMed Web of Science ®Google Scholar
• Klein ML, Ferris FL, 3rd, Armstrong J, AREDS Research Group, et al. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology. 2008;115(6):1026–1031.
   PubMed Web of Science ®Google Scholar
• Rasoulinejad SA, Zarghami A, Hosseini SR, et al. Prevalence of age-related macular degeneration among the elderly. Caspian J Intern Med. 2015;6(3):141–147.
   PubMed Web of Science ®Google Scholar
• Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13(6):438–451.
   PubMed Web of Science ®Google Scholar
• Celkova L, Doyle SL, Campbell M. NLRP3 Inflammasome and Pathobiology in AMD. J Clin Med. 2015;4(1):172–192.
   PubMed Web of Science ®Google Scholar
• Iyer SS, Pulskens WP, Sadler JJ, et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA. 2009;106(48):20388–20393.
   PubMed Web of Science ®Google Scholar
• Kauppinen A, Niskanen H, Suuronen T, et al. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration (AMD). Immunol Lett. 2012;147(1-2):29–33.
   PubMed Web of Science ®Google Scholar
• Hanus J, Anderson C, Wang S. RPE necroptosis in response to oxidative stress and in AMD. Ageing Res Rev. 2015;24(Pt B):286–298.
   PubMedGoogle Scholar
• Doyle SL, Campbell M, Ozaki E, et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med. 2012;18(5):791–798.
   PubMed Web of Science ®Google Scholar
• Mariner PD, Walters RD, Espinoza CA, et al. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell. 2008;29(4):499–509.
   PubMed Web of Science ®Google Scholar
• Brandstetter C, Mohr LK, Latz E, et al. Light induces NLRP3 inflammasome activation in retinal pigment epithelial cells via lipofuscin-mediated photooxidative damage. J Mol Med. 2015;3(8):905–916.
   Google Scholar
• Doyle SL, Adamson P, López FJ, et al. Reply to IL-18 is not therapeutic for neovascular age-related macular degeneration. Nat Med. 2014;20(12):1376–1377.
   PubMed Web of Science ®Google Scholar
• Doyle SL, Ozaki E, Brennan K, et al. IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration. Sci Transl Med. 2014;6(230):230ra44.
   PubMed Web of Science ®Google Scholar
• Shen J, Choy DF, Yoshida T, et al. Interleukin‐18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF. J Cell Physiol. 2014;229(8):974–983.
   PubMed Web of Science ®Google Scholar
• Rasoulinejad SA, Hajian-Tilaki K, Mehdipour E. Associated factors of diabetic retinopathy in patients that referred to teaching hospitals in Babol. Caspian J Intern Med. 2015;6(4):224–228.
   PubMed Web of Science ®Google Scholar
• Rubsam A, Parikh S, Fort PE. Role of inflammation in diabetic retinopathy. IJMS. 2018;19(4):942.
   Google Scholar
• Semeraro F, Morescalchi F, Cancarini A, et al. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications. Diabetes and Metabolism. 2019;45(6):517–527.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol. 2004;88(10):1343–1347.
   PubMed Web of Science ®Google Scholar
• Ting DS, Tan KA, Phua V, et al. Biomarkers of diabetic retinopathy. Curr Diab Rep. 2016;16(12):125.
   PubMed Web of Science ®Google Scholar
• Sasongko MB, Wong TY, Jenkins AJ, et al. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Diabet Med. 2015;32(5):686–691.
   PubMed Web of Science ®Google Scholar
• Xu H, Chen M. Diabetic retinopathy and dysregulated innate immunity. Vision Res. 2017;139:39–46.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Matsumoto H, Roh M, et al. Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ. 2014;21(2):270–277.
   PubMed Web of Science ®Google Scholar
• Gnanaguru G, Choi AR, Amarnani D, et al. Oxidized lipoprotein uptake through the CD36 receptor activates the NLRP3 inflammasome in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2016;57(11):4704–4712.
   PubMed Web of Science ®Google Scholar
• Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007;356(15):1517–1526.
   PubMed Web of Science ®Google Scholar
• So A, De Smedt T, Revaz S, et al. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther. 2007;9(2):R28.
   PubMed Web of Science ®Google Scholar
• Hu C, Ding H, Li Y, et al. NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. Proc Natl Acad Sci USA. 2015;112(36):11318–23.
   PubMed Web of Science ®Google Scholar
• Mohr S, Xi X, Tang J, et al. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes. 2002;51(4):1172–1179.
   PubMed Web of Science ®Google Scholar
• Devi TS, Lee I, Huttemann M, et al. TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp Diabetes Res. 2012;2012:438238.
   PubMedGoogle Scholar
• Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 2015;8:15–27.
   PubMed Web of Science ®Google Scholar
• Xu S, Li X, Liu Y, et al. Inflammasome inhibitors: promising therapeutic approaches against cancer. J Hematol Oncol. 2019;12(1):64.
   PubMedGoogle Scholar
• Liu Y, Yao W, Xu J, et al. The anti-inflammatory effects of acetaminophen and N-acetylcysteine through suppression of the NLRP3 inflammasome pathway in LPS-challenged piglet mononuclear phagocytes. Innate Immun. 2015;21(6):587–597.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Mueller JL, Vitari AC, et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol. 2009;187(1):61–70.
   PubMed Web of Science ®Google Scholar
• Weber FC, Esser PR, Muller T, et al. Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J Exp Med. 2010;207(12):2609–2619.
   PubMed Web of Science ®Google Scholar
• Wilhelm K, Ganesan J, Muller T, et al. Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat Med. 2010;16(12):1434–1438.
   PubMed Web of Science ®Google Scholar
• Keating C, Pelegrin P, Martinez CM, et al. P2X7 receptor-dependent intestinal afferent hypersensitivity in a mouse model of postinfectious irritable bowel syndrome. J Immunol. 2011;187(3):1467–1474.
   PubMed Web of Science ®Google Scholar
• Labasi JM, Petrushova N, Donovan C, et al. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol. 2002;168(12):6436–6445.
   PubMed Web of Science ®Google Scholar
• Pelegrin P. Targeting interleukin-1 signaling in chronic inflammation: focus on P2X(7) receptor and Pannexin-1. Drug News Perspect. 2008;21(8):424–433.
   PubMedGoogle Scholar
• Arulkumaran N, Unwin RJ, Tam FW. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs. 2011;20(7):897–915.
   PubMed Web of Science ®Google Scholar
• López-Castejón G, Pelegrín P. Current status of inflammasome blockers as anti-inflammatory drugs. Expert Opin Investig Drugs. 2012;21(7):995–1007.
   PubMed Web of Science ®Google Scholar
• Wannamaker W, Davies R, Namchuk M, et al. (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18. J Pharmacol Exp Ther. 2007;321(2):509–516.
   PubMed Web of Science ®Google Scholar
• Vincent JA, Mohr S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes. 2007;56(1):224–230.
   PubMed Web of Science ®Google Scholar